Schutten, Martin

Publishing since 2007 (Baby)

Has published 15 publications in 4 years

Number of publications published per year by Schutten, Martin. (Source : PubMed)

Distribution of publications types for Schutten, Martin. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.  J. Clin. Virol.  2010;47;1  
•  de Pagter AP, Haveman LM, Schuurman R, Schutten M, Bierings M, Boelens JJ. Adenovirus DNA positivity in nasopharyngeal aspirate preceding hematopoietic stem cell transplantation: a very strong risk factor for adenovirus DNAemia in pediatric patients.  Clin. Infect. Dis.  2009;49;10  
•  Meijer A, Beerens A, Claas E, Hermans M, de Jong A, Molenkamp R, Niesters H, Overduin P, Rossen J, Schuurman R, Wolffs P, Fouchier R, Osterhaus A, Schutten M, Koopmans M. Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant.  J. Clin. Virol.  2009;45;3  
•  van Asten L, van der Lubben M, van den Wijngaard C, van Pelt W, Verheij R, Jacobi A, Overduin P, Meijer A, Luijt D, Claas E, Hermans M, Melchers W, Rossen J, Schuurman R, Wolffs P, Bouchier C, Schirm J, Kroes L, Leenders S, Galama J, Peeters M, van Loon A, Stobberingh E, Schutten M, Koopmans M. Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks.  J. Clin. Virol.  2009;45;3  
•  van Houdt R, Koedijk FD, Bruisten SM, Coul EL, Heijnen ML, Waldhober Q, Veldhuijzen IK, Richardus JH, Schutten M, van Doornum GJ, de Man RA, Hahné SJ, Coutinho RA, Boot HJ. Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?  Vaccine  2009;27;27  
•  Reijnders JG, Pas SD, Schutten M, de Man RA, Janssen HL. Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.  J. Hepatol.  2009;50;4  
•  Beersma MF, Schutten M, Vennema H, Hartwig NG, Mes TH, Osterhaus AD, van Doornum GJ, Koopmans M. Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children.  J. Hosp. Infect.  2009;71;3  
•  Reijnders JG, Leemans WF, Hansen BE, Pas SD, de Man RA, Schutten M, Janssen HL. On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.  J. Viral Hepat.  2009;16;2  
•  Baars J, Boon B, De Wit JB, Schutten M, Van Steenbergen JE, Garretsen HF, Van De Mheen D. Drug users' participation in a free hepatitis B vaccination program: demographic, behavioral, and social-cognitive determinants.  Subst Use Misuse  2008;43;14  
•  van der Vries E, van den Berg B, Schutten M. Fatal oseltamivir-resistant influenza virus infection.  N. Engl. J. Med.  2008;359;10  

[ See timeline ] [ See all publications ]